Sustained MYB activity is necessary for oncogenic transcription in KMT2A-rearranged acute lymphoblastic leukemia through enhancer-promoter interactions and epigenetic modifications at enhancers
Lau I-J., Harman JR., Jackson NE., Denny N., Smith AL., Vyas P., Davies JO., Hughes J., Crump N., Milne TA.